The UroLift system, a new device for relieving the urinary tract problems caused by enlarged prostate glands in men is recommended in new NICE guidance.
The UK’s National Institute for Health and Care Excellence (NICE) provides guidance, standards and information on the provision of high quality health and social care. As such it is called upon to assess and make recommendations about many devices and therapeutic solutions, adopting its Medical Technologies Evaluation Programme (MTEP) to do so.
Covered on our pages numerous times in the past, Urolift is recommended for treating the symptoms of benign prostatic hyperplasia – a condition where an enlarged prostate can push against the urethra, making it difficult for a man to pass urine. Using the UroLift system involves inserting implants to move the excess prostate tissue away from the urethra, which stops the extra tissue blocking the flow of urine. The system avoids the need to cut or remove the extra prostate tissue, which are the methods commonly used to treat a urine blockage caused by an enlarged prostate.
NICE announced in May that it was to consult on the Urolift device, and this new announcement summarises its findings, concluding that in patients aged 50 years or older with urinary tract symptoms, where the size of their prostate is less than 100cm3 there are clear reasons to advicate its use. The benefits of the system include avoiding risk to sexual function, and a reduced length of hospital stay because treatment with UroLift can be carried out as a day procedure. The guidance estimates that savings of up £286 per patient could be made using this system when compared with other treatments.
Full guidance can be found here.
Professor Carole Longson MBE, Director of the NICE Centre for Health Technology Evaluation, said: “We’re pleased to publish this new guidance recommending the UroLift system for treating enlarged prostates in men over 50 years old with urinary tract symptoms. An enlarged prostate gland can lead to problems in passing urine and other urinary tract symptoms for many men as they get older. Based on the evidence examined, the independent Medical Technologies Advisory Committee concluded that as well as benefiting patients it’s also likely to benefit the NHS by saving money when used in day surgery.”